Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda
April 9, 2026
New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included
1 min read
False
Advertisement
Cell & Gene
Immune-Stealth DNA Enables Safer, Large-Scale Genome Writing
April 8, 2026
Circular single-stranded donors help recombinases bypass immune defenses, unlocking in vivo gene insertion
2 min read
Sartorius Unveils Platform Aimed at Scaling Autologous Cell Therapy
April 7, 2026
New Eveo system is designed to raise CAR-T output, cut manufacturing costs, and ease cleanroom bottlenecks
1 min read
CAR-T Cells Target Alzheimer’s Plaques
April 6, 2026
Engineered immune cells clear amyloid and improve brain health in mice, offering a new direction for neurodegenerative therapy
1 min read
CAR Tregs Move Into Neurodegeneration
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
Could Mass Spec Overcome the CAR T Solid Tumor Barrier?
April 1, 2026
Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.
6 min read
From One Stem Cell to Millions of Cancer Killers
April 1, 2026
A three-step engineering strategy generates vast numbers of potent NK immune cells – potentially slashing the cost and scaling of cancer immunotherapy
1 min read
AstraZeneca Deepens China Cell Therapy Push
March 31, 2026
New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration
1 min read
CRISPR Enables In Vivo CAR T Cell Production
March 30, 2026
In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing
1 min read
